New advances in brain-targeting nano-drug delivery systems for Alzheimer's disease

Cdk5 Inhibitory Peptide Prevents Loss of Neurons and Alleviates Behavioral Changes in p25 Transgenic Mice

(2020) Yaowei Huang et al.   JOURNAL OF ALZHEIMERS DISEASE

Overcoming blood–brain barrier transport: Advances in nanoparticle-based drug delivery strategies

(2020) Shichao Ding et al.   Materials Today

Targetting Exosomes as a New Biomarker and Therapeutic Approach for Alzheimer’s Disease

(2020) Qingqing Yin et al.   Clinical Interventions in Aging

Application of the Nano-Drug Delivery System in Treatment of Cardiovascular Diseases

(2020) Yudi Deng et al.   Frontiers in Bioengineering and Biotechnology

Dual-Sensitive Nanomicelles Enhancing Systemic Delivery of Therapeutically Active Antibodies Specifically into the Brain

(2020) Jinbing Xie et al.   ACS Nano

Neuronal mitochondria-targeted delivery of curcumin by biomimetic engineered nanosystems in Alzheimer's disease mice

(2020) Chunhong Gao et al.   Acta Biomaterialia

Endo/Lysosome‐Escapable Delivery Depot for Improving BBB Transcytosis and Neuron Targeted Therapy of Alzheimer's Disease

(2020) Lulu Cai et al.   ADVANCED FUNCTIONAL MATERIALS

Immunoglobulins on the surface of differently charged polymer nanoparticles

(2020) Domenik Prozeller et al.   Biointerphases

Neuronal mitochondria-targeted micelles relieving oxidative stress for delayed progression of Alzheimer's disease

(2020) Peng Yang et al.   BIOMATERIALS

Treatment of Alzheimer's disease with framework nucleic acids

(2020) Xiaoru Shao et al.   CELL PROLIFERATION

Neuron tau-targeting biomimetic nanoparticles for curcumin delivery to delay progression of Alzheimer’s disease

(2020) Chunhong Gao et al.   JOURNAL OF NANOBIOTECHNOLOGY

Current understanding of metal ions in the pathogenesis of Alzheimer’s disease

(2020) Lu Wang et al.   Translational Neurodegeneration

Tauopathy Analysis in P301S Mouse Model of Alzheimer Disease Immunized with DNA and MVA Poxvirus-Based Vaccines Expressing Human Full-Length 4R2N or 3RC Tau Proteins

(2020) Juan García-Arriaza et al.   Vaccines

A Biocompatible Second Near-Infrared Nanozyme for Spatiotemporal and Non-Invasive Attenuation of Amyloid Deposition through Scalp and Skull

(2020) Mengmeng Ma et al.   ACS Nano

The physiological roles of tau and Aβ: implications for Alzheimer’s disease pathology and therapeutics

(2020) Sarah A. Kent et al.   ACTA NEUROPATHOLOGICA

Viral nanoparticles for drug delivery, imaging, immunotherapy, and theranostic applications

(2020) Young Hun Chung et al.   ADVANCED DRUG DELIVERY REVIEWS

Brain Microvascular Endothelial Cell Derived Exosomes Potently Ameliorate Cognitive Dysfunction by Enhancing the Clearance of Aβ Through Up-Regulation of P-gp in Mouse Model of AD

(2020) Junlu Pan et al.   NEUROCHEMICAL RESEARCH

Liposome-mediated delivery of challenging chemicals to aid environmental assessment of Bioaccumulative (B) and Toxic (T) properties

(2020) Mafalda Castro et al.   Scientific Reports

Progress of RAGE Molecular Imaging in Alzheimer’s Disease

(2020) Yanyan Kong et al.   Frontiers in Aging Neuroscience

Intranasal delivery of mesenchymal stem cell‐derived extracellular vesicles exerts immunomodulatory and neuroprotective effects in a 3xTg model of Alzheimer's disease

(2020) Morris Losurdo et al.   Stem Cells Translational Medicine

A Novel Targeted and High‐Efficiency Nanosystem for Combinational Therapy for Alzheimer's Disease

(2020) Han Yang et al.   Advanced Science

Engineered hepatitis B core virus-like particle carrier for precise and personalized Alzheimer’s disease vaccine preparation via fixed-point coupling

(2020) Mei Ji et al.   Applied Materials Today

Engineering endogenous ABC transporter with improving ATP supply and membrane flexibility enhances the secretion of β-carotene in Saccharomyces cerevisiae

(2020) Xiao Bu et al.   Biotechnology for Biofuels

Blood-brain barrier–penetrating siRNA nanomedicine for Alzheimer’s disease therapy

(2020) Yutong Zhou et al.   Science Advances

Recognition and Removal of Amyloid‐β by a Heteromultivalent Macrocyclic Coassembly: A Potential Strategy for the Treatment of Alzheimer's Disease

(2020) Hui Wang et al.   ADVANCED MATERIALS

Carbon nitride-based nanocaptor: An intelligent nanosystem with metal ions chelating effect for enhanced magnetic targeting phototherapy of Alzheimer's disease

(2020) Ling Gong et al.   BIOMATERIALS

Macrophage membrane-coated nanocarriers Co-Modified by RVG29 and TPP improve brain neuronal mitochondria-targeting and therapeutic efficacy in Alzheimer's disease mice

(2020) Yang Han et al.   Bioactive Materials

Activation of microglia and astrocytes: a roadway to neuroinflammation and Alzheimer’s disease

(2019) Darshpreet Kaur et al.   INFLAMMOPHARMACOLOGY

Transferrin receptor 1 overexpression is associated with tumor dedifferentiation and acts as a potential prognostic indicator of hepatocellular carcinoma

(2019) Makiko Adachi et al.   HISTOPATHOLOGY

Therapeutic strategies targeting amyloid-β in Alzheimer’s disease

(2019) Lídia Pinheiroa et al.   Current Alzheimer Research

Codelivery of Plasmid and Curcumin with Mesoporous Silica Nanoparticles for Promoting Neurite Outgrowth

(2019) Cheng-Shun Cheng et al.   ACS Applied Materials & Interfaces

A review of magnet systems for targeted drug delivery

(2019) Ya-Li Liu et al.   JOURNAL OF CONTROLLED RELEASE

Microglia-mediated neuroinflammation in neurodegenerative diseases

(2019) Charannya Sozheesvari Subhramanyam et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

RVG-modified exosomes derived from mesenchymal stem cells rescue memory deficits by regulating inflammatory responses in a mouse model of Alzheimer’s disease

(2019) Guo-hong Cui et al.   Immunity & Ageing

AAV9-Mediated Cdk5 Inhibitory Peptide Reduces Hyperphosphorylated Tau and Inflammation and Ameliorates Behavioral Changes Caused by Overexpression of p25 in the Brain

(2019) Miaojing Xu et al.   JOURNAL OF ALZHEIMERS DISEASE

Protein-Capped Metal Nanoparticles Inhibit Tau Aggregation in Alzheimer’s Disease

(2019) Shweta Kishor Sonawane et al.   ACS Omega

Lactoferrin Coupled Lower Generation PAMAM Dendrimers for Brain Targeted Delivery of Memantine in Aluminum-Chloride-Induced Alzheimer’s Disease in Mice

(2019) Avinash Gothwal et al.   BIOCONJUGATE CHEMISTRY

Microglia in Alzheimer Disease: Well-Known Targets and New Opportunities

(2019) Anne-Laure Hemonnot et al.   Frontiers in Aging Neuroscience

aFGF Promotes Neurite Growth by Regulating GSK3β-CRMP2 Signaling Pathway in Cortical Neurons Damaged by Amyloid-β

(2019) Qin Cao et al.   JOURNAL OF ALZHEIMERS DISEASE

Cell Membrane Coating Technology: A Promising Strategy for Biomedical Applications

(2019) Yao Liu et al.   Nano-Micro Letters

An “Amyloid‐β Cleaner” for the Treatment of Alzheimer's Disease by Normalizing Microglial Dysfunction

(2019) Ruiyuan Liu et al.   Advanced Science

The solute carrier transporters and the brain: physiological and pharmacological implications

(2019) Chengliang Hu et al.   Asian Journal of Pharmaceutical Sciences

Mitochondria-targeted TPP-MoS2 with dual enzyme activity provides efficient neuroprotection through M1/M2 microglial polarization in an Alzheimer's disease model

(2019) Chaoxiu Ren et al.   BIOMATERIALS

P‐glycoprotein: a role in the export of amyloid‐β in Alzheimer's disease?

(2019) Amanda B. Chai et al.   FEBS Journal

Receptor specific, stimuli responsive and subcellular targeted approaches for effective therapy of Alzheimer: Role of surface engineered nanocarriers

(2019) Divya Gopalan et al.   JOURNAL OF CONTROLLED RELEASE

The Regulatory Functionality of Exosomes Derived from hUMSCs in 3D Culture for Alzheimer's Disease Therapy

(2019) Lingyan Yang et al.   Small

Ferritin Nanocarrier Traverses the Blood Brain Barrier and Kills Glioma

(2018) Kelong Fan et al.   ACS Nano

Alzheimer’s disease pathology propagation by exosomes containing toxic amyloid-beta oligomers

(2018) Maitrayee Sardar Sinha et al.   ACTA NEUROPATHOLOGICA

Alzheimer’s Disease and Parkinson’s Disease: A Review of Current Treatment Adopting a Nanotechnology Approach

(2018) Adriana Trompetero et al.   CURRENT PHARMACEUTICAL DESIGN

Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease

(2018) Qingqing Meng et al.   International Journal of Nanomedicine

Crossing the blood-brain barrier with nanoparticles

(2018) Yiqun Zhou et al.   JOURNAL OF CONTROLLED RELEASE

Use of functionalized liposomes loaded with antioxidants to permeate the blood–brain barrier and inhibit β-amyloid-induced neurodegeneration in the brain

(2018) Yung-Chih Kuo et al.   Journal of the Taiwan Institute of Chemical Engineers

Exosomes: a novel therapeutic target for Alzheimer’s disease?

(2018) Zhi-You Cai et al.   Neural Regeneration Research

Targeted inhibition of RAGE reduces amyloid-β influx across the blood-brain barrier and improves cognitive deficits in db/db mice

(2018) Hao Wang et al.   NEUROPHARMACOLOGY

Inhibition of amyloid beta fibril formation by monomeric human transthyretin

(2018) Kanchan Garai et al.   PROTEIN SCIENCE

Tailored surface silica nanoparticles for blood-brain barrier penetration: Preparation and in vivo investigation

(2018) B.I. Tamba et al.   Arabian Journal of Chemistry

Cell membrane-based nanoparticles: a new biomimetic platform for tumor diagnosis and treatment

(2018) Ruixiang Li et al.   Acta Pharmaceutica Sinica B

Oral Brain-Targeted Microemulsion for Enhanced Piperine Delivery in Alzheimer’s Disease Therapy: In Vitro Appraisal, In Vivo Activity, and Nanotoxicity

(2018) Samar M. Etman et al.   AAPS PHARMSCITECH

Identification of novel immune-relevant drug target genes for Alzheimer's Disease by combining ontology inference with network analysis

(2018) Zhi-Jie Han et al.   CNS Neuroscience & Therapeutics

Exosomes and microRNAs: New potential therapeutic candidates in Alzheimer disease therapy

(2018) Elmira Iranifar et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Blood-Brain Barrier Transport, Plasma Pharmacokinetics, and Neuropathology Following Chronic Treatment of the Rhesus Monkey with a Brain Penetrating Humanized Monoclonal Antibody Against the Human Transferrin Receptor

(2018) William M. Pardridge et al.   MOLECULAR PHARMACEUTICS

Recent progress of drug nanoformulations targeting to brain

(2018) Abdur Rauf Khan et al.   JOURNAL OF CONTROLLED RELEASE

Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response

(2018) Sara Bachiller et al.   Frontiers in Cellular Neuroscience

Microenvironment Remodeling Micelles for Alzheimer's Disease Therapy by Early Modulation of Activated Microglia

(2018) Yifei Lu et al.   Advanced Science

Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer’s disease –conformist, nonconformist, and realistic prospects for AD pathogenesis

(2018) Hongmei Li et al.   Translational Neurodegeneration

Adeno-associated virus 9–mediated Cdk5 inhibitory peptide reverses pathologic changes and behavioral deficits in the Alzheimer’s disease mouse model

(2017) Yong He et al.   FASEB JOURNAL

Neuroprotection against apoptosis of SK-N-MC cells using RMP-7- and lactoferrin-grafted liposomes carrying quercetin

(2017) Yung-Chih Kuo et al.   International Journal of Nanomedicine

Cell-penetrating peptides (CPPs): From delivery of nucleic acids and antigens to transduction of engineered nucleases for application in transgenesis

(2017) Gandhi Rádis-Baptista et al.   JOURNAL OF BIOTECHNOLOGY

Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease

(2017) Mukta Agrawal et al.   JOURNAL OF CONTROLLED RELEASE

Dementia prevention, intervention, and care

(2017) Gill Livingston et al.   LANCET

Resveratrol and Grape Extract-loaded Solid Lipid Nanoparticles for the Treatment of Alzheimer’s Disease

(2017) Joana Loureiro et al.   MOLECULES

Noninvasive nanoparticle strategies for brain tumor targeting

(2017) Chunmeng Sun et al.   Nanomedicine-Nanotechnology Biology and Medicine

Chronic Cerebral Hypoperfusion Promotes Amyloid-Beta Pathogenesis via Activating β/γ-Secretases

(2017) Zhiyou Cai et al.   NEUROCHEMICAL RESEARCH

Blood-brain barrier–adapted precision medicine therapy for pediatric brain tumors

(2017) Bernard L. Marini et al.   Translational Research

On the path to 2025: understanding the Alzheimer’s disease continuum

(2017) Paul S. Aisen et al.   Alzheimers Research & Therapy

Antibody-conjugated mesoporous silica nanoparticles for brain microvessel endothelial cell targeting

(2017) Meryem Bouchoucha et al.   Journal of Materials Chemistry B

Host–pathogen interactions in bacterial meningitis

(2016) Kelly S. Doran et al.   ACTA NEUROPATHOLOGICA

Structural differences between amyloid beta oligomers

(2016) Leonid Breydo et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease

(2016) Amy R. Nelson et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Brain-targeted co-delivery of therapeutic gene and peptide by multifunctional nanoparticles in Alzheimer's disease mice

(2016) Yang Liu et al.   BIOMATERIALS

Mitochondrial dysfunction and cell death in neurodegenerative diseases through nitroxidative stress

(2016) Mohammed Akbar et al.   BRAIN RESEARCH

Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer’s disease treatment

(2016) Joana A. Loureiro et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting

(2016) Fanfei Meng et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Polymer-based drug delivery systems for cancer treatment

(2016) Xing Guo et al.   JOURNAL OF POLYMER SCIENCE PART A-POLYMER CHEMISTRY

Transferrin-modified liposome promotes α-mangostin to penetrate the blood–brain barrier

(2016) Zhi-Lan Chen et al.   Nanomedicine-Nanotechnology Biology and Medicine

Exosomes in Alzheimer's disease

(2016) Tarja Malm et al.   NEUROCHEMISTRY INTERNATIONAL

Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer’s mice

(2016) Arne Ittner et al.   SCIENCE

Strategies for transporting nanoparticles across the blood–brain barrier

(2016) Tian-Tian Zhang et al.   Biomaterials Science

Exosomes as therapeutic drug carriers and delivery vehicles across biological membranes: current perspectives and future challenges

(2016) Dinh Ha et al.   Acta Pharmaceutica Sinica B

Sialic acid (SA)-modified selenium nanoparticles coated with a high blood–brain barrier permeability peptide-B6 peptide for potential use in Alzheimer’s disease

(2015) Tiantian Yin et al.   Acta Biomaterialia

BBB-targeting, protein-based nanomedicines for drug and nucleic acid delivery to the CNS

(2015) Hugo Peluffo et al.   BIOTECHNOLOGY ADVANCES

Structural differences of amyloid-β fibrils revealed by antibodies from phage display

(2015) Patrick Droste et al.   BMC BIOTECHNOLOGY

A novel LDL-mimic nanocarrier for the targeted delivery of curcumin into the brain to treat Alzheimer's disease

(2015) Fanfei Meng et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Chitosan coated nanostructured lipid carriers for brain delivery of proteins by intranasal administration

(2015) Oihane Gartziandia et al.   COLLOIDS AND SURFACES B-BIOINTERFACES

Endothelial LRP1 transports amyloid-β1–42 across the blood-brain barrier

(2015) Steffen E. Storck et al.   JOURNAL OF CLINICAL INVESTIGATION

Targeted endothelial nanomedicine for common acute pathological conditions

(2015) Vladimir V. Shuvaev et al.   JOURNAL OF CONTROLLED RELEASE

Intranasal Piperine-Loaded Chitosan Nanoparticles as Brain-Targeted Therapy in Alzheimer's Disease: Optimization, Biological Efficacy, and Potential Toxicity

(2015) Yosra S.R. Elnaggar et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Prophylactic melatonin significantly reduces Alzheimer’s neuropathology and associated cognitive deficits independent of antioxidant pathways in AβPPswe/PS1 mice

(2015) G. O’Neal-Moffitt et al.   Molecular Neurodegeneration

GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration

(2015) Ethan A Winkler et al.   NATURE NEUROSCIENCE

Tau and neurodegenerative disease: the story so far

(2015) Khalid Iqbal et al.   Nature Reviews Neurology

Tau in physiology and pathology

(2015) Yipeng Wang et al.   NATURE REVIEWS NEUROSCIENCE

Cell-Penetrating Peptides Selectively Cross the Blood-Brain Barrier In Vivo

(2015) Sofie Stalmans et al.   PLoS One

Insulin and insulin-like growth factor receptors in the brain: Physiological and pathological aspects

(2014) Haim Werner et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

The blood-brain barrier: Structure, function and therapeutic approaches to cross it

(2014) Marta Tajes et al.   MOLECULAR MEMBRANE BIOLOGY

Expression of P-glycoprotein, multidrug resistance-associated protein, glutathione-S-transferase pi and p53 in canine transmissible venereal tumor

(2014) Daniel G. Gerardi et al.   PESQUISA VETERINARIA BRASILEIRA

Enhanced Oral Delivery of Curcumin from N-trimethyl Chitosan Surface-Modified Solid Lipid Nanoparticles: Pharmacokinetic and Brain Distribution Evaluations

(2014) Prakash Ramalingam et al.   PHARMACEUTICAL RESEARCH

Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery

(2013) Ru Cheng et al.   BIOMATERIALS

Activated protein C inhibits amyloid β production via promoting expression of ADAM-10

(2013) Bing Li et al.   BRAIN RESEARCH

The ornithine effect in peptide cation dissociation

(2013) William M. McGee et al.   JOURNAL OF MASS SPECTROMETRY

Celecoxib attenuates systemic lipopolysaccharide-induced brain inflammation and white matter injury in the neonatal rats

(2013) L.-W. Fan et al.   NEUROSCIENCE

Nanoparticle Mediated P-Glycoprotein Silencing for Improved Drug Delivery across the Blood-Brain Barrier: A siRNA-Chitosan Approach

(2013) Jostein Malmo et al.   PLoS One

Glucose-Coated Gold Nanoparticles Transfer across Human Brain Endothelium and Enter Astrocytes In Vitro

(2013) Radka Gromnicova et al.   PLoS One

P-glycoprotein mediated efflux limits substrate and drug uptake in a preclinical brain metastases of breast cancer model

(2013) Chris E. Adkins et al.   Frontiers in Pharmacology

Bacterium-Like Particles for Efficient Immune Stimulation of Existing Vaccines and New Subunit Vaccines in Mucosal Applications

(2013) Natalija Van Braeckel-Budimir et al.   Frontiers in Immunology

Na+-K+-ATPase, a potent neuroprotective modulator against Alzheimer disease

(2012) Li-Nan Zhang et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Insulin receptor-independent upregulation of cellular glucose uptake

(2012) R Krishnapuram et al.   INTERNATIONAL JOURNAL OF OBESITY

Doxil® — The first FDA-approved nano-drug: Lessons learned

(2012) Yechezkel (Chezy) Barenholz   JOURNAL OF CONTROLLED RELEASE

Development of a novel model for comparative evaluation of intranasal pharmacokinetics and effects of anti-allergic nasal sprays

(2011) Daniel Baumann et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Dual-targeted polyplexes: One step towards a synthetic virus for cancer gene therapy

(2011) Yu Nie et al.   JOURNAL OF CONTROLLED RELEASE

Low-Density Lipoprotein Receptor–Related Protein Is Decreased in Optic Neuropathy of Alzheimer Disease

(2011) Lloyd M Cuzzo et al.   JOURNAL OF NEURO-OPHTHALMOLOGY

In Vivo Labeling of Brain Capillary Endothelial Cells after Intravenous Injection of Monoclonal Antibodies Targeting the Transferrin Receptor

(2011) S. Paris-Robidas et al.   MOLECULAR PHARMACOLOGY

Hydrophilic coating of mitotane-loaded lipid nanoparticles: Preliminary studies for mucosal adhesion

(2011) Patrícia Severino et al.   PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY

Nanoparticles enhance brain delivery of blood-brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging

(2011) R. M. Koffie et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Development of New Therapeutics for Alzheimer's Disease

(2010) M D Carter et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

APPswe/Aβ regulation of osteoclast activation and RAGE expression in an age-dependent manner

(2010) Shun Cui et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Targeting the insulin receptor: nanoparticles for drug delivery across the blood–brain barrier (BBB)

(2010) Karsten Ulbrich et al.   JOURNAL OF DRUG TARGETING

Importance of intermolecular interaction on the improvement of intestinal therapeutic peptide/protein absorption using cell-penetrating peptides

(2009) Noriyasu Kamei et al.   JOURNAL OF CONTROLLED RELEASE

Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide

(2008) Steve Oh et al.   CANCER LETTERS

The Role of the Cell Surface LRP and Soluble LRP in Blood-Brain Barrier Aβ Clearance in Alzheimers Disease

(2008) R. Deane et al.   CURRENT PHARMACEUTICAL DESIGN

Delivery of nanoparticles to the brain detected by fluorescence microscopy

(2008) Isolde Reimold et al.   EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS

Tight junctions and the modulation of barrier function in disease

(2008) Carola Förster   HISTOCHEMISTRY AND CELL BIOLOGY

Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector Angiopep-2

(2008) Michel Demeule et al.   JOURNAL OF NEUROCHEMISTRY